Literature DB >> 11434814

From the Food and Drug Administration.

B A Schwetz1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11434814     DOI： 10.1001/jama.286.1.35

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  How we will treat chronic myeloid leukemia in 2016.

Authors:  Chetasi Talati; Evelena P Ontiveros; Elizabeth A Griffiths; Eunice S Wang; Meir Wetzler
Journal:  Blood Rev       Date:  2014-12-17       Impact factor: 8.250

2.  Imatinib-induced fatal acute liver failure.

Authors:  Ezequiel Ridruejo; Roberto Cacchione; Alejandra G Villamil; Sebastián Marciano; Adrián C Gadano; Oscar G Mandó
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

3.  New results will change the paradigm for phase I trials and drug approval.

Authors:  Bruce A Chabner
Journal:  Oncologist       Date:  2010-10-07

4.  Hepatic iron overload, a possible consequence of treatment with imatinib mesylate: a case report.

Authors:  Baidehi Maiti; Sebouh Setrakian; Hamed A Daw
Journal:  Cases J       Date:  2009-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.